Viewing Study NCT02961803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-02-25 @ 6:30 PM
Study NCT ID: NCT02961803
Status: COMPLETED
Last Update Posted: 2017-10-09
First Post: 2016-11-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: MD1003-AMN MD1003 in Adrenomyeloneuropathy
Sponsor: MedDay Pharmaceuticals SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adrenomyeloneuropathy View
None Adrenoleukodystrophy View
None AMN View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AMN View
None MD1003 View
None Adrenomyeloneuropathy View
None ALD View
None Adrenoleukodystrophy View
None Biotin View
None 2MWT View
None Two-minute walk test View
None TW25 View
None Timed 25-Foot Walk View